Table 4.

Remaining fluorescent intensity and complications after nipple-sparing mastectomy and prosthetic breast reconstruction.^*

Fluorescent Intensity by Incision Type
	All patients (n=79)	IMF (n=55)	LR (n=24)	P
Post-NSM, breast overall	62.9 ± 26.1 %	63.9 ± 26.6%	60.8 ± 25.4%	0.6
Post-recon, breast overall	31.9 ± 14.4%	30.6 ± 13.0%	35.1 ± 17. %	0.2
Post-NSM, nipple	33.0 ± 26.7%	29.9 ± 24.2%	40.0 ± 31.1%	0.1
Post recon, nipple	25.7 ± 23.07%	23.2 ± 22.0%	31.3 ± 24.9%	0.2
Post-NSM, inferior	59.8 ± 32.3%	54.6 ± 32.2%	72.0 ± 30.0%	0.02
Post-recon, inferior	26.5 ± 19.4%	21.9 ± 17.6%	36.9 ± 22.6%	0.001
Post-NSM, lateral	74.4 ± 49.0%	73.5 ± 53.3 %	76.5 ± 38.4%	0.8
Post-recon, lateral	28.4 ± 20.6%	23.01 ± 16.0%	40.7 ± 24.8%	0.003
Post-NSM, medial	63.3 ± 31.3%	62.5 ± 30.8%	65.2 ± 33.2%	0.6
Post-recon, medial	29.2 ± 18.4%	28.0 ± 23.3%	32.1 ± 20.7%	0.3
Complications by Incision Type
	All patients (n=79)	IMF (n=55)	LR (n=24)	P
Any Necrosis	21 (26.5%)	16 (29.1%)	5 (20.8%)	0.2
Nipple tip necrosis	16 (20.2%)	13 (23.6%)	3 (12.5%)	0.5
Nipple loss	1 (1.3%)	1 (1.8%)	0	0.1
Flap necrosis	8 (10.1%)	6 (10.9%)	2 (8.3%)	0.95
Infection	8 (10.1%)	6 (10.9%)	2 (8.3%)	0.5
Hematoma	3 (3.8%)	3 (5.5%)	0	0.6
Seroma	5 (6.3%)	4 (7.3%)	1 (4.2%)	1
Device malposition	6 (7.6%)	5 (9.1%)	1 (4.2%)	0.7
Implant exposure	0	0	0	1
Wound dehiscence	2 (2.5%)	1 (1.8%)	1 (4.2%)	0.5
Total OR trips	1.6 ± 0.7	1.6 ± 0.8	1.6 ± 0.6	0.9
Explant	4 (5.1%)	4 (7.3%)	0	0.3

^*Values presented as a percentage of the original preoperative fluorescent intensity, minus background fluorescence, based on 0-255 unit, 8-bit greyscale.